(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

SAL DE (R)-9-(2,5-DIFLUOROFENETIL)-4-ETIL-2-METIL-1-OXA-4,9- DIAZAESPIRO[5.5]UNDECAN-3-ONA, COMPOSIÇÃO FARMACÊUTICA CONTENDO O MESMO E SEU USO

Em AnáliseInvention PatentPCT · EP2018000470

Application data

Number

112020007359

Type

Invention Patent

Filing

10/16/2018

Publication

09/29/2020

PCT

EP2018000470

Progress at the INPI

Technical opinion to answer
  1. Filing10/16/18
  2. Publication09/29/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/14/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

A. T. (pessoa física)

ES

ESTEVE PHARMACEUTICALS, S.A.

ES

Inventors

C. A. (pessoa física)

ES

N. T. (pessoa física)

ES

Technical data

Priority claims

EP

17 382 695.9 · 10/17/2017

Abstract

A presente invenção refere-se aos sais de (R)-9-(2,5-difluorofenetil)-4-etil-2-metil-1-oxa-4,9-diazaespiro[5.5] undecan-3-ona, a composições farmacêuticas compreendendo-os, e ao seu uso em terapia e/ou profilaxia de doenças associadas com receptor sigma e/ou receptor µ-opioide.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

05/14/2024

RPI 2784

Parecer de pré-exame

#6.23

08/23/2022

RPI 2694

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

09/29/2020

RPI 2595

Alteração de dados cadastrais

#1.1

09/08/2020

RPI 2592

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.